#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Diabetes and obesity - Issue 46/2023

Editorial

Prevalence of obesity and type 2 diabetes mellitus

Reviews

87
Screening for diabetic retinopathy in diabetic outpatient clinics using arteficial intelligence: a pilot project of the Slovak Diabetes Society

Viera Doničová

91
Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)

Jozef Lacka, Emil Martinka, Petra Ištokovičová, Tamara Vraždová, Peter Jackuliak

103
Benefit of early treatment with dapagliflozin in primary prevention in patients with type 2 diabetes mellitus

Jozef Lacka, Barbora Lacková

113
Cardio-renal and metabolic benefits of empagliflozin: additional indication and change in indication restrictions

Ingrid Dravecká

118
Obesity and heart failure with preserved ejection fraction – dapagliflozin also shows clinical benefit here

Ján Murín

125
The SGLT2 inhibitor canagliflozin: a comprehensive effect in the treatment of type 2 diabetes mellitus

Zbynek Schroner


News

127
International Peace Marathon – try once, love forever!

Olga Bobelová


News

128
Summary of the 59th Annual Congress of the European Association for the Study of Diabetes

Peter Novodvorský


Personal news

133
Remembrance of JUDr. Eva Madajová
134
In memoriam MUDr. Evy Virčíkovej

Personalities

130
MUDr. Martina Merčiaková, MBA – portrét ambulantnej diabetologičky
131
MUDr. Ján Truban – portrét ambulantného diabetológa

Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#